The relationship between erectile dysfunction and stroke risk is clinically important because an erection depends on healthy blood vessels, responsive endothelium, intact nerves, and adequate blood flow. When erectile function changes persistently, the cause may be local or psychological, but it can also reflect the same vascular injury that contributes to ischemic stroke. Erectile dysfunction (ED) does not mean that a stroke is imminent. It may, however, provide an opportunity to identify high blood pressure, diabetes, abnormal cholesterol, smoking exposure, or subclinical atherosclerosis before a major cardiovascular event occurs.
Why Erectile Dysfunction and Stroke Risk Can Overlap
Most strokes are ischemic: blood flow to part of the brain is interrupted by a clot or a narrowed artery. Vascular ED develops through related biology. Sexual stimulation normally triggers nitric oxide release in penile tissue. Nitric oxide activates cyclic guanosine monophosphate, relaxes smooth muscle, increases arterial inflow, and helps trap blood within the erectile tissue. Endothelial dysfunction, arterial stiffness, inflammation, and atherosclerosis can weaken this sequence.
The penile arteries are smaller than the coronary and carotid arteries. Under the “artery size” hypothesis, a comparable burden of endothelial injury or plaque may become functionally apparent in smaller vessels earlier than in larger ones. This is one reason ED can precede recognized cardiovascular disease in some men. It is not a perfect screening test: erections are also affected by anxiety, depression, medications, hormone disorders, neurologic disease, pelvic surgery, sleep loss, alcohol, and relationship factors.
ED and stroke also share conventional risk factors. Hypertension injures the vessel lining and accelerates arterial remodeling. Diabetes impairs endothelial function and peripheral nerves. Smoking reduces nitric oxide availability and promotes thrombosis. Obesity, physical inactivity, sleep apnea, chronic kidney disease, and abnormal lipids can add to the risk of both conditions. The overlap means that persistent ED deserves more than a prescription-focused conversation.
What Recent Studies Say About Stroke Risk
Large observational studies consistently find an association, although the size of the estimate differs by population and study design. A 2021 umbrella review by Mostafaei and colleagues pooled evidence from systematic reviews and meta-analyses. Men with ED had a 36% higher relative risk of stroke than men without ED. The same analysis found higher risks of coronary heart disease, myocardial infarction, cardiovascular mortality, and all-cause mortality.[1] An association of this kind cannot prove that ED itself causes stroke; shared vascular risk can drive both outcomes.
More recent evidence adds detail. In a 2024 NHANES analysis of 1,207 U.S. men, Mei and colleagues found that ED was associated with a higher calculated 10-year risk of atherosclerotic cardiovascular disease. After adjustment, men with ED had 2.27 times the odds of being in the high-risk ASCVD category.[2] Because the study was cross-sectional and used older NHANES cycles, it cannot establish which condition came first. Its value is in reinforcing ED as a possible signal of an unfavorable cardiovascular profile.
A 2025 analysis by Zhang and colleagues combined NHANES observations with Mendelian randomization. Men who reported never being able to obtain and maintain an erection had 2.42 times the adjusted odds of a history of stroke compared with men reporting preserved function. The genetic analysis also found modest associations between genetically predicted ED and large-artery or small-vessel stroke.[3] Mendelian randomization can reduce some forms of confounding, but it still depends on genetic-instrument assumptions and should not be interpreted as proof that treating ED prevents stroke.
Data from the opposite direction are relevant too. In a 2024 study of 287 men admitted with acute stroke or transient ischemic attack, Schjørring and colleagues found that 40.4% reported ED predating the event. ED was associated with age, but not with stroke severity or the measured modifiable cardiovascular risk factors.[4] That finding is a useful restraint: ED is common among men with stroke, yet it is not a precise measure of how severe a future event will be.
Erectile Dysfunction as a Cardiovascular Risk Marker
The 2024 Princeton IV Consensus recommends treating ED as a cardiovascular risk marker and risk-enhancing factor, especially when the cause appears vascular.[5] This does not mean every man with ED needs cardiac imaging. It means erectile symptoms should prompt a structured assessment rather than being treated as an isolated quality-of-life complaint.
An initial evaluation commonly includes blood pressure, smoking status, body mass index or waist measurement, physical activity, family history, fasting lipids, and glucose or hemoglobin A1c. Clinicians may also review kidney function, sleep-apnea symptoms, medications, and testosterone when the history suggests a hormonal problem. The presence of chest discomfort, exertional breathlessness, fainting, or reduced exercise tolerance changes the urgency and scope of the assessment.
For men without known cardiovascular disease, a clinician can estimate 10-year ASCVD risk using age, cholesterol, blood pressure, diabetes, and smoking information. Princeton IV suggests that coronary artery calcium scoring may help refine risk in selected men with predominantly vascular ED who otherwise fall into a borderline or intermediate category.[5] Calcium scoring is not appropriate for everyone, and stroke risk also depends on conditions not fully captured by coronary calcium, including atrial fibrillation and carotid disease.
Importantly, relative risk and absolute risk are different. A younger man may have a meaningful relative increase but still have a low short-term absolute risk. Conversely, an older man with hypertension, diabetes, and smoking exposure may already have a high baseline risk. The purpose of screening is to place the erectile symptom in the person’s total clinical context.
When Erectile Symptoms Need Prompt Evaluation
ED that develops gradually over months often fits a chronic vascular, metabolic, medication-related, or psychogenic pattern. A medical appointment is appropriate when symptoms persist for several weeks, are worsening, occur across settings, or are accompanied by reduced exercise capacity. Evaluation is particularly important for men under 60 with no known explanation, because ED can be a comparatively early vascular symptom in this group.
Sudden neurologic symptoms are different and require emergency action, regardless of whether ED is present. Facial drooping, arm weakness, speech difficulty, abrupt loss of vision, severe imbalance, or a sudden unexplained headache may indicate stroke. Emergency services should be contacted immediately; waiting to see whether symptoms resolve can eliminate the window for time-sensitive treatment.
Sexual activity itself is generally comparable to mild-to-moderate physical exertion, but men with unstable angina, uncontrolled hypertension, advanced heart failure symptoms, recent untreated myocardial infarction, or high-risk arrhythmias need cardiovascular stabilization before resuming sexual activity.[5] Men who can perform moderate exercise without chest pain or disproportionate breathlessness are often lower risk, though individual assessment still matters.
Medication review is essential. Nitrates used for angina must not be combined with phosphodiesterase type 5 (PDE5) inhibitors because the interaction can cause a dangerous fall in blood pressure. Recreational nitrites carry the same risk. Alpha-blockers, antihypertensives, and other medicines may require timing or dose considerations under clinician supervision. Never stop a cardiovascular drug independently because of suspected sexual side effects; safer substitutions may be available.
Reducing Shared Vascular Risk
The strongest risk-reduction measures are familiar because they affect the entire vascular system. Blood-pressure control, smoking cessation, diabetes management, lipid treatment when indicated, regular exercise, adequate sleep, and a dietary pattern centered on minimally processed foods may support endothelial health and lower cardiovascular risk. Some men experience improved erectile function as these factors improve, but response varies and lifestyle change should not be presented as a guaranteed ED treatment.
Aerobic activity is especially relevant. Moderate exercise can improve blood pressure, insulin sensitivity, cardiorespiratory fitness, and nitric oxide signaling. A practical target for many adults is at least 150 minutes of moderate-intensity activity per week plus resistance exercise, adjusted for medical status and current fitness. A man with exertional symptoms should be assessed before starting an aggressive program.
PDE5 inhibitors can support erections by slowing the breakdown of cyclic guanosine monophosphate, but they do not remove arterial plaque or replace cardiovascular prevention. They also require sexual stimulation to work. Treatment response, adverse effects, timing, food intake, and concurrent medication use should be reviewed with a prescriber. Persistent nonresponse may point to severe vascular disease, incorrect use, low sexual desire, nerve injury, pelvic-floor dysfunction, or another diagnosis requiring a different approach.
Conclusion
Erectile dysfunction is common and usually has more than one contributor. The evidence supports viewing persistent ED as a possible marker of vascular risk, not as a diagnosis of impending stroke. Cohort studies, meta-analyses, and recent consensus guidance all support checking cardiovascular risk factors when ED appears, while also recognizing that association does not establish causation. A complete evaluation can address sexual function and identify treatable risks involving blood pressure, glucose, cholesterol, smoking, sleep, and physical activity.
If you're exploring clinically-formulated options, OnyxMD offers physician-supervised treatment plans, including Red Pill, starting with a free online assessment at questionnaire.getonyxmd.com. You can also review additional evidence-based men's health articles on the blog.
These statements have not been evaluated by the FDA. This content is for informational purposes only and does not constitute medical advice.
References
Mostafaei H, Mori K, Hajebrahimi S, et al. Association of erectile dysfunction and cardiovascular disease: an umbrella review of systematic reviews and meta-analyses. BJU International. 2021;128(1):3-11. doi:10.1111/bju.15313
Mei Y, Chen Y, Wang X, Xu R, Xu R, Feng X. Association between erectile dysfunction and the predicted 10-year risk for atherosclerosis cardiovascular disease among U.S. men: a population-based study from the NHANES 2001-2004. Frontiers in Endocrinology. 2024;15:1442904. doi:10.3389/fendo.2024.1442904
Zhang B, Yang Q, Sun H, Liu M, Liang H, Ji H. Erectile dysfunction increases the risk of stroke: evidence from NHANES and Mendelian randomization analysis. Translational Andrology and Urology. 2025;14(10):3042-3052. doi:10.21037/tau-2025-396
Schjørring CB, Eddelien HS, Butt JH, Kruuse C. High prevalence of erectile dysfunction in male patients with acute stroke was associated with age but not to modifiable cardiovascular risk factors. BMJ Neurology Open. 2024;6:e000795. doi:10.1136/bmjno-2024-000795
Kloner RA, Burnett AL, Miner M, et al. Princeton IV consensus guidelines: PDE5 inhibitors and cardiac health. The Journal of Sexual Medicine. 2024;21(2):90-116. doi:10.1093/jsxmed/qdad163
Medical Disclaimer: The information provided on this website is for educational and informational purposes only and is not intended as medical advice. OnyxMD services should not be used to diagnose, treat, cure, or prevent any disease or medical condition. Always consult with a qualified healthcare provider before beginning any supplement regimen or health program.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Individual Results: Results may vary. The experiences and testimonials presented on this website are individual results that may not be typical. Your experience may be different.
Telehealth Services: OnyxMD provides telehealth services in 47 states (excluding AK, MS, NJ) through licensed healthcare providers via our partner Beluga Health, P.A. Services are subject to clinical evaluation and may not be appropriate for all individuals. Prescriptions fulfilled by Strive Pharmacy LLC (License #99-9817) and EPIQ SCRIPTS LLC.